Target intelligence / Profile preview

Cathepsin H (CTSH)

Target
CTSH
Molecular classification
Enzyme, Cysteine protease, Lysosomal protease, Peptidase C1 family, Papain family
01

Overview

Cathepsin H is a lysosomal cysteine protease in the papain family, encoded by the CTSH gene in humans. It is unique among cathepsins for its predominant aminopeptidase activity, although it can also function as an endopeptidase. Synthesized as a proenzyme, cathepsin H is proteolytically processed into a heavy and light chain and retains a mini-chain essential for its aminopeptidase activity. It plays a major role in lysosomal protein degradation and is involved in diverse physiological processes such as intracellular turnover, extracellular matrix remodeling, and activation of cytotoxic granule components in immune cells. Cathepsin H shows increased expression in various pathologies, including cancers (notably prostate), inflammation, and infection, and is explored as a potential therapeutic target and disease biomarker. Endogenous cystatin family inhibitors tightly regulate its activity, while pharmacological inhibition remains an area of therapeutic research.

Other names
Aminopeptidase HCathepsin H (CTSH)CTSH
02

Mechanism of action

Proteolytic inhibition (blocking cysteine protease activity), Modulation of aminopeptidase activity

03

Biological functions

Protein degradationIntracellular protein turnoverExtracellular matrix remodelingImmune responseActivation of cytotoxins
04

Disease associations

CancerInflammationInfectionOther (e.g., arthritis, periodontitis)
05

Safety considerations

Off-target effects of cysteine protease inhibitorsBroad substrate specificity may cause disruption of essential lysosomal functionsRedundancy with other cathepsins may complicate therapeutic specificity
06

Interacting drugs

Various experimental small-molecule inhibitors

1 more in the full profile.

07

Biomarkers

Overexpression in certain cancers (prostate, colorectal)Altered expression in various disease states (potential use as a diagnostic/prognostic biomarker)

Beyond the preview

Go deeper on Cathepsin H (CTSH).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cathepsin H (CTSH).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call